COMMUNIQUÉS West-GlobeNewswire

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
13/01/2026
Seasoned leader with global commercialization and marketing expertise SOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (“Aligos”, Nasdaq: ALGS), a clinical stage biopharmaceutical [...]
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
13/01/2026
SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
13/01/2026
-- LG Chem becomes exclusive distributor of EXPAREL -- – Partnership expands patient access to opioid-sparing pain control and advances 5x30 strategy– BRISBANE, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pacira [...]
Evaxion expands AI-Immunology™ platform into autoimmune diseases
13/01/2026
Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focus In future, Evaxion’s proprietary AI-Immunology™ platform will enable the discovery and development of drug candidates targeting [...]
Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa
13/01/2026
Tokyo, Japan and Cambridge, UK, 13 January 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Centessa Pharmaceuticals has achieved an early development milestone associated with its [...]
Bio Usawa Receives Ghana FDA Approval for BioUcenta™
13/01/2026
Ghana follows Rwanda in approving BioUcenta™, Africa’s first approved ranibizumab biosimilar ACCRA, Ghana and KIGALI, Rwanda, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa, Inc.) today [...]
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
13/01/2026
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences Schlieren (Zürich), Switzerland, January 13, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic [...]
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
13/01/2026
January 13, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today [...]
Checkerspot and La Fabrique Végétale Partner to Commercialize Algal Oils in the European Personal Care Market
13/01/2026
Fermentation-Derived Algal Oils Meet Their Moment as Next-Generation Ingredients for European Cosmetic and Personal Care Brands Alameda, Calif (USA) and Lyon (FRANCE), Jan. 13, 2026 (GLOBE NEWSWIRE) -- Checkerspot , a [...]
Basilea joins INCATE to support antifungal innovation
13/01/2026
Allschwil, Switzerland, January 13, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]
Wegovy Pill vs Wegovy Shot: Oral vs Injectable Semaglutide Differences — 2026 FDA Launch Analysis via Ro.co
13/01/2026
Comprehensive comparison of daily oral vs weekly injectable Wegovy following Novo Nordisk's January 2026 FDA approval of the first oral GLP-1 for chronic weight management — Ro.co telehealth access pathway examination [...]
Metabo Drops 2026: Is It Legit? Ingredients, Safety Facts, and Consumer Analysis
13/01/2026
Consumer searches for supplement legitimacy increased 26% year-over-year as transparency becomes central purchasing criterion — industry analysis examines what drives "Is It Legit?" search behavior and how liquid [...]
Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia
12/01/2026
- SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant in the Phase 1b FALCON trial has been completed, with initial data expected in H2 2026, [...]
IBA SA – NOTIFICATION TRANSPARENCE
12/01/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 12 janvier 2026, 22:30 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
IBA – TRANSPARENCY NOTIFICATION
12/01/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 12, 2026 10:30 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
CareMed Has Been Selected as a National Specialty Pharmacy Provider for MYQORZO™ (aficamten)
12/01/2026
NEW HYDE PARK, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- CareMed ® , an independent specialty pharmacy, has been selected as a pharmacy partner by Cytokinetics for MYQORZO™ ( aficamten ), indicated for the treatment of [...]
Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
12/01/2026
WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026
12/01/2026
BANNOCKBURN, Ill., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion [...]
Best Electrolyte Supplement Analysis 2026: Seaonic Challenges Top Hydration Packets With Ocean-Sourced Minerals
13/01/2026
A deep-dive into what's driving the shift toward seawater-derived electrolytes—and how Seaonic's published disclosures compare with common verification criteria DENVER, CO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disclaimer: [...]

Pages